{"id":"https://openalex.org/W2151921086","doi":"https://doi.org/10.1046/j.1464-5491.2002.00774.x","title":"Improved glycaemic control with metformin\u2013glibenclamide combined tablet therapy (Glucovance\u00ae) in Type 2 diabetic patients inadequately controlled on metformin","display_name":"Improved glycaemic control with metformin\u2013glibenclamide combined tablet therapy (Glucovance\u00ae) in Type 2 diabetic patients inadequately controlled on metformin","alternate_titles":[],"publication_year":2002,"publication_date":"2002-07-30","ids":{"openalex":"https://openalex.org/W2151921086","doi":"https://doi.org/10.1046/j.1464-5491.2002.00774.x","mag":"2151921086","pmid":"https://pubmed.ncbi.nlm.nih.gov/12147149"},"language":"en","primary_location":{"id":"doi:10.1046/j.1464-5491.2002.00774.x","doi":"https://doi.org/10.1046/j.1464-5491.2002.00774.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1464-5491.2002.00774.x","pdf_url":null,"source":{"id":"https://openalex.org/S72944096","display_name":"Diabetic Medicine","issn_l":"0742-3071","issn":["0742-3071","1096-9136","1464-5491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2151921086"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088350286","display_name":"Michel Marre","orcid":"https://orcid.org/0000-0002-3071-1837","observed_orcids":["https://orcid.org/0000-0002-3071-1837"]},"institutions":[{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"M. Marre","raw_affiliation_strings":["Diabetology-Endocrinology-Metabolism Unit, Hospital of Xavier Bichat, 46 Rue Henri Huchard, 75877 Paris Cedex 18, France","Centre Hospitalier Universitaire X Bichat, Paris and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetology-Endocrinology-Metabolism Unit, Hospital of Xavier Bichat, 46 Rue Henri Huchard, 75877 Paris Cedex 18, France","institution_ids":["https://openalex.org/I4210145170"]},{"raw_affiliation_string":"Centre Hospitalier Universitaire X Bichat, Paris and","institution_ids":["https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113477656","display_name":"H. C. S. Howlett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Howlett","raw_affiliation_strings":["Merck Lipha, Lyon, France, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Lipha, Lyon, France, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020254926","display_name":"P. Lehert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130929987","display_name":"University of Mons","ror":"https://ror.org/02qnnz951","country_code":"BE","type":"education","lineage":["https://openalex.org/I130929987"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"P. Lehert","raw_affiliation_strings":["Faculte\u0301s Catholiques de Mons, Mons, Belgium","Facult\u00e9s Catholiques de Mons, Mons, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculte\u0301s Catholiques de Mons, Mons, Belgium","institution_ids":["https://openalex.org/I130929987"]},{"raw_affiliation_string":"Facult\u00e9s Catholiques de Mons, Mons, Belgium","institution_ids":["https://openalex.org/I130929987"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070906215","display_name":"Thierry Allavoine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Allavoine","raw_affiliation_strings":["Merck Lipha, Lyon, France, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Lipha, Lyon, France, and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5088350286"],"corresponding_institution_ids":["https://openalex.org/I4210145170"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":3.7573,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.94679132,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"19","issue":"8","first_page":"673","last_page":"680"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9520000219345093},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.746999979019165},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.5860000252723694},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9879999756813049},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.640999972820282},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7820000052452087},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.5230000019073486},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6669999957084656},{"id":"https://openalex.org/keywords/plasma-lipids","display_name":"plasma lipids","score":0.640999972820282},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.8989999890327454},{"id":"https://openalex.org/keywords/monotherapy-comparison","display_name":"monotherapy comparison","score":0.5770000219345093},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.9908360242843628},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.9844756126403809},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9047579169273376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6380125880241394},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5914165377616882},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.570135235786438},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5436441898345947},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4282868802547455}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019270","descriptor_name":"Fructosamine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1046/j.1464-5491.2002.00774.x","doi":"https://doi.org/10.1046/j.1464-5491.2002.00774.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1464-5491.2002.00774.x","pdf_url":null,"source":{"id":"https://openalex.org/S72944096","display_name":"Diabetic Medicine","issn_l":"0742-3071","issn":["0742-3071","1096-9136","1464-5491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic Medicine","raw_type":"journal-article"},{"id":"pmid:12147149","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12147149","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic medicine : a journal of the British Diabetic Association","raw_type":"Clinical Trial"},{"id":"pmh:oai:dial.uclouvain.be:boreal:20207","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078/20207","pdf_url":null,"source":{"id":"https://openalex.org/S4306400166","display_name":"Digital Access to Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800384882","host_organization_name":"Harris County Public Library","host_organization_lineage":["https://openalex.org/I2800384882"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetic Medicine, Vol. 19, p. 673-680 (2002)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332194","display_name":"Johnson and Johnson","ror":"https://ror.org/03qd7mz70"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W8744681","https://openalex.org/W129305155","https://openalex.org/W1964423574","https://openalex.org/W1975588287","https://openalex.org/W1976560200","https://openalex.org/W1979782841","https://openalex.org/W1990414793","https://openalex.org/W1998420557","https://openalex.org/W2005408361","https://openalex.org/W2021142183","https://openalex.org/W2036939737","https://openalex.org/W2039553698","https://openalex.org/W2043316108","https://openalex.org/W2047752191","https://openalex.org/W2053365438","https://openalex.org/W2059649085","https://openalex.org/W2089477934","https://openalex.org/W2121971720","https://openalex.org/W2123946565","https://openalex.org/W2129862407","https://openalex.org/W2134126803","https://openalex.org/W2138470202","https://openalex.org/W2154434917","https://openalex.org/W2166640752","https://openalex.org/W2169563211","https://openalex.org/W2172692903","https://openalex.org/W2188846692","https://openalex.org/W2324992560","https://openalex.org/W2331274940","https://openalex.org/W2337454357","https://openalex.org/W2462205608","https://openalex.org/W2786617581","https://openalex.org/W3109617681","https://openalex.org/W4235700900","https://openalex.org/W4245367233","https://openalex.org/W6652790575"],"related_works":["https://openalex.org/W2003474285","https://openalex.org/W2083951055","https://openalex.org/W2418536877","https://openalex.org/W1588680373","https://openalex.org/W112046146","https://openalex.org/W2176639197","https://openalex.org/W2079229392","https://openalex.org/W2096999369","https://openalex.org/W4234956512"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"evaluate":[2],"the":[3,19,66,237,251],"efficacy":[4],"and":[5,85,98,101,106,113,119,129,138,148,172,179,207,235],"safety":[6],"of":[7,11,131,163,222,239,245],"two":[8,198],"dosage":[9],"strengths":[10],"a":[12,227],"single-tablet":[13],"metformin-glibenclamide":[14,55,60,93,134,168,229],"(glyburide)":[15],"combination,":[16],"compared":[17,109,143,249],"with":[18,24,65,110,144,167,184,226,250],"respective":[20,252],"monotherapies,":[21,253],"in":[22,81,197,210],"patients":[23,44,132,199],"Type":[25,223],"2":[26,224],"diabetes":[27],"mellitus":[28],"(DM)":[29],"inadequately":[30],"controlled":[31],"by":[32,127],"metformin":[33,49,111,151,164,189,246],"monotherapy.":[34],"METHODS:":[35],"In":[36],"this":[37],"16-week,":[38],"double-blind,":[39],"multicentre,":[40],"parallel-group":[41],"trial,":[42],"411":[43],"were":[45,87,157,205,213],"randomized":[46],"to":[47,68],"receive":[48],"500":[50,56,61,94,102,135,139,169,173],"mg,":[51,54,63,141],"glibenclamide":[52,117,147,166,185,248],"5":[53],"mg/2.5":[57,95,136,170],"mg":[58,96,104,137,171,175,178],"or":[59,75,116,165,188,215,247],"mg/5":[62,103,140,174],"titrated":[64],"intention":[67],"achieve":[69],"fasting":[70],"plasma":[71],"glucose":[72],"(FPG)":[73],"<":[74,90,123,214],"=":[76,153,216],"7":[77],"mmol/l.":[78],"RESULTS:":[79],"Decreases":[80],"glycated":[82],"haemoglobin":[83],"(HbA1c)":[84],"FPG":[86],"greater":[88],"(P":[89,152],"0.05)":[91],"for":[92,146,150],"(-1.20%":[97],"-2.62":[99],"mmol/l)":[100,115],"(-0.91%":[105],"-2.34":[107],"mmol/l),":[108],"(-0.19%":[112],"-0.57":[114],"(-0.33%":[118],"-0.73":[120],"mmol/l).":[121],"HbA1c":[122],"7%":[124],"was":[125],"achieved":[126,158],"75%":[128],"64%":[130],"receiving":[133,200],"respectively,":[142],"42%":[145],"38%":[149],"0.001).":[154],"These":[155],"benefits":[156],"at":[159,242],"lower":[160,243],"mean":[161,208],"doses":[162,244],"(1225":[176],"mg/6.1":[177],"1170":[180],"mg/11.7":[181],"mg)":[182,187],"than":[183],"(13.4":[186],"(1660":[190],"mg).":[191],"Treatment-related":[192],"serious":[193],"adverse":[194],"events":[195],"occurred":[196],"glibenclamide.":[201],"Plasma":[202],"lipid":[203],"profiles":[204],"unaffected":[206],"changes":[209],"body":[211],"weight":[212],"1.0":[217],"kg.":[218],"CONCLUSIONS:":[219],"Intensive":[220],"management":[221],"DM":[225],"new":[228],"combination":[230],"tablet":[231],"improved":[232],"glycaemic":[233,240],"control":[234],"facilitated":[236],"attainment":[238],"targets":[241],"without":[254],"compromising":[255],"tolerability.":[256]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2151921086","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
